Product Description: AS601245 is an orally active, selective, ATP competitive JNK (c-Jun NH2-terminal protein kinase) inhibitor with IC50s of 150, 220, and 70 nM for three JNK human isoforms (hJNK1, hJNK2, and hJNK3), respectively. AS601245 exhibits 10- to 20-fold selectivity over c-src, CDK2, and c-Raf and more than 50- to 100-fold selectivity over a range of Ser/Thr- and Tyr-protein kinases. Neuroprotective properties[1][2].
Applications: Cancer-Kinase/protease
Formula: C20H16N6S
References: [1]Carboni S, et al. AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J Pharmacol Exp Ther. 2004;310(1):25-32.
CAS Number: 345987-15-7
Molecular Weight: 372.45
Compound Purity: 98.83
Research Area: Cancer; Inflammation/Immunology; Neurological Disease
Solubility: DMSO : 10 mg/mL (ultrasonic)
Target: JNK
Deutsch
English
